Prelude Therapeutics Incorporated (PRLD)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
4. 20
+0.02
+0.4785%
$
249.93M Market Cap
- P/E Ratio
- Div Yield
180,700 Volume
-2 Eps
$ 4.18
Previous Close Investors:
Want to track PRLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Prelude Therapeutics Incorporated (PRLD) Statistics
Valuation metrics
Market Cap 249.93M
Enterprise value 235.08M
Trailing P/E (ttm) -3.96
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 14.3
Price/Book (mrq) 5.76
Enterprise Value/Revenue 14.06
Enterprise Value/EBITDA -3.09
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 160.53K
Average volume (90 days) 477.57K
Price summary
52-Week low 0.75
52-Week high 5.69
Beta -
50-Day moving average 4.26
200-Day moving average 3.36
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.65%
Operating margin -5.03%
Operational effectiveness
Return on assets -0.65%
Return on equity -1.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.99
Total debt (mrq) -
Total Debt/Equity (mrq) 0.29
Current ratio (mrq) 2.03%
Book value per share (mrq) 0.73
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
